Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-028730
Filing Date
2015-05-08
Accepted
2015-05-08 14:11:31
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v408511_10q.htm 10-Q 304949
2 EXHIBIT 31.1 v408511_ex31-1.htm EX-31.1 11451
3 EXHIBIT 31.2 v408511_ex31-2.htm EX-31.2 11668
4 EXHIBIT 32.1 v408511_ex32-1.htm EX-32.1 5893
  Complete submission text file 0001144204-15-028730.txt   4599295

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ecyt-20150331.xml EX-101.INS 771379
6 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20150331.xsd EX-101.SCH 28652
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20150331_cal.xml EX-101.CAL 27384
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20150331_def.xml EX-101.DEF 182687
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20150331_lab.xml EX-101.LAB 261560
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20150331_pre.xml EX-101.PRE 223023
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 15845839
SIC: 2834 Pharmaceutical Preparations